Clearing of psoriasis by a novel immunosuppressive macrolide

Journal of Investigative Dermatology

Volumn 106, Issue 4, 1996, Pages 701-710

  Rappersberger, Klemens ^a   Meingassner, Josef G ^b   Fialla, Rolf ^a   Födinger, Dagmar ^a   Sterniczky, Barbara ^a   Rauch, Silvia ^a   Putz, Eva ^a   Stütz, Anton ^b   Wolff, Klaus ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Ascomycin; Topical immunosuppressive therapy

Indexed keywords

CLOBETASOL PROPIONATE; MACROLIDE; PLACEBO; SDZ 281240; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE ACTIVATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030010432     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12345542     Document Type: Article

References (45)

1. Altmeyer PJ, Matthes U, Pawlak. F: Antipsoriatic effect of fumaric acid derivatives. J Am Acad Dermatol 30:977-981, 1994
2. Baadsgaard O, Gupta AK, Taylor RS, Ellis CN, Voorhees JJ, Cooper KD: Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J Invest Dermatol 92:190-195, 1989
3. Baker B, Fry L: The immunology of psoriasis. Brit J Dermatol 126:1-9, 1992
4. Baker BS, Powles AV, Savage CR, McFadden JP, Valdimarsson H, Fry L: Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell subpopulations. Br J Dermatol 120:207-213, 1989
5. Baker JN, Karabin GD, Stoof TJ, Sarma VJ, Dixit VM, Nickoloff BJ: Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci 2:106-211, 1991
6. Bernerd F, Magnaldo T, Darmon M: Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 98:902-910, 1992
7. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneous immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
8. Eedy DF, Burrows, Bridges JM, Jones FGC: Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br Med J 300:908, 1990
9. Ellis CN, Gorsulowsky DC, Hamilton TA: Cyclosporin improves psoriasis in a double-blind study. J Am Med Assoc 256:3110-3116, 1986
10. Ellis CN, Voorhees JJ: Etretinate therapy. J Am Acad Dermatol 16:267-291, 1987
11. Elder JT, Naiv RP, Voorhees JJ: Epidemology and the genetics of psoriasis. J Invest Dermatol 102:24s-27s, 1994
12. Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Saint Andre JP, Verret JL: Psoriasis after allogeneic bone marrow transplantation. Arch Dermatol 126:1523, 1990
13. Gearing AJ, Fincham NJ, Bird CR: Cytokines in skin lesions of psoriasis. Cytokine 2:68-75, 1990
14. Gottlieb AB, Lifshitz B, Fu SM, Strausse-Coico L, Wang CY, Carter DM: Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 164:1013-1028, 1986
15. Gottlieb AB, Grossman KM, Khandake L: Studies on the effect of cyclosporin in psoriasis in vivo: combined effects in activated T lymphocytes and epidermal regenerative lymphocytes and epidermal regenerative maturation. J Invest Dermatol 98:302-309, 1992
16. 389 IL-2) suggest a primary immune hut not keratinocyte pathogenic basis. Nature Med 1:442-447, 1995
17. Grassberger MA, Baumann K: Macrolide immunosuppressants. Curr Opin Ther Patents 1993, pp 931-949
18. Griffiths CEM, Powles AV, McFadden J, Baker BS, Valdimarsson H, Fry L: Long term cyclosporin for psoriasis. Br J Dermatol 120:253-260, 1989
19. Griffiths CEM: Cutaneous leucocyte trafficking and psoriasis. Arch Dermatol 130:494-499, 1994
20. Griffiths CEM, Powles AV, Baker BS, Fry L, Valdimarsson H: Topical cyclosporin and psoriasis. Lancet 1:806, 1987
21. Gupta AK, Baadsgaard OP, Ellis CN, Vouchees JJ, Cooper KD: Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells are depleted by treatment with cyclosporin A. Arch Dermatol Res 281:219-226, 1989
22. Ho VC, Griffiths CEM, Ellis CN: Intralesional cyclosporine in the treatment of psoriasis: a clinical immunologie and pharmacogenetic study. J Am Acad Dermatol 22:94-100, 1990
23. Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Abu-Elmagd K, Starzl TE: Tacrolimus (FK506): a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 128:781-785, 1992
24. Krueger GG, Duvic M: Epidemiology of psoriasis: clinical issues. J Invest Dermatol 102:14s-18s, 1994
25. Meingassner JG, Stütz A: Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 98:851-855, 1992
26. Meo T: MLR in the mouse. In: Lefkovits F, Pernis B. (eds). Immunological Methods: Academic Press, New York, 1979, pp 227-239
27. Mihatsch MJ, Wolff K: Consensus conference on cyclosporin A for psoriasis, February 1992. Br J Dermatol 126:621-623, 1992
28. Morel P, Revillard JP, Nicolas JF, Wijdenes J, Rizova H, Thivolet J: Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Antoimmun 5:465-477, 1992
29. Nicolas JF, Chamchich N, Thivolet J, Wijdenes J, Morel P, Revillard JP: CD4 antibody treatment of severe psoriasis. Lancet 338:321, 1991
30. Petzelbauer P, Stingl G, Wolff K, Volc-Platzer B: Cyclosporin A suprresses ICAM-1 expression by papillary endothelium in healing psoriatic plauqes. J Invest Dermatol 96:362-369, 1991
31. Petzelhauer P, Pober JS, Keh A, Braverman IM: Inducibility and expression of micro vascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients: J Invest Dermatol 103:300-305, 1994
32. Prinz J, Braun-Falco O, Meurer M: Chimeric CD4 monoclonal antibody in treatment of generalized pustular psoriasis. Lancet 338:320-321, 1991
33. Rappersberger K, Tschachler E, Zonzits E: Endemic Kaposi's sarcoma in human immunodeficiency virus type-1 seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 95:371-381, 1990
34. Schlaak JF, Buslau M, Jochum W: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102(2):145-149, 1994
35. Skehan P, Storeng R, Scudiero D: New colorimetric assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112, 1990
36. Strange P, Cooper KD, Hansen ER: T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 101:695-700, 1993
37. Strong DM, Ahmed AA, Thurman GB, Sell KW: In vitro stimulation of murine spleen cells using a microculture system and a multiple automated sample harvester. J Immunol Methods 2:279-287, 1973
38. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nikoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T helper type 1 cell-mediated response. J Invest Dermatol 101:701-705, 1993
39. Vallat VP, Gilleandeaux P, Battat L: PUVA bath therapy strongly suppresses immuological and epidermal activation in psoriasis: a possible cellular basis for remithive therapy. J Exp Med 180:283-296, 1994
40. Wakita H, Takigawa M: E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 130:457-463, 1994
41. Weinshenker BG, Bass BH, Ebers GC, Rice GPA: Remission of psoriatic lesions with muromonab CD3 (Orthoclone OKT3) treatment. J Am Acad Dermatol 20:1132-1133, 1989
42. Weinstein GD, McCullough JL: Cytokinetics and chemotherapy of psoriasis. J Invest Dermatol 67:26-30, 1976
43. Winiski AP, Foster CA: ICAM-1 expression in a spontaneously transformed human keratinocyte cell line: characterization by a simple cell-ELISA assay. J Invest Dermatol 99:48-52, 1992
44. Wolff K, Hönigsmann H: Clinical aspects of photochemotherapy. Pharmacol Ther 12:381-418, 1981
45. Wong RL, Winslow CM, Cooper KD: The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol Today 14:69-74, 1993